Eicosanoids
Origin and metabolism. The eicosanoids,
prostaglandins, thromboxane,
prostacyclin, and leukotrienes, are
formed in the organism from arachidonic
acid, a C20 fatty acid with four
double bonds (eicosatetraenoic acid).
Arachidonic acid is a regular constituent
of cell membrane phospholipids; it is
released by phospholipase A2 and forms
the substrate of cyclooxygenases and
lipoxygenases.
Synthesis of prostaglandins (PG),
prostacyclin, and thromboxane proceeds
via intermediary cyclic endoperoxides.
In the case of PG, a cyclopentane
ring forms in the acyl chain. The letters
following PG (D, E, F, G, H, or I) indicate
differences in substitution with hydroxyl
or keto groups; the number subscripts
refer to the number of double
bonds, and the Greek letter designates
the position of the hydroxyl group at C9
(the substance shown is PGF2!). PG are
primarily inactivated by the enzyme 15-
hydroxyprostaglandindehydrogenase.
Inactivation in plasma is very rapid;
during one passage through the lung,
90% of PG circulating in plasma are degraded.
PG are local mediators that attain
biologically effective concentrations
only at their site of formation.
Biological effects. The individual
PG (PGE, PGF, PGI = prostacyclin) possess
different biological effects.
Nociceptors. PG increase sensitivity
of sensory nerve fibers towards ordinary
pain stimuli (p. 194), i.e., at a given
stimulus strength there is an increased
rate of evoked action potentials.
Thermoregulation. PG raise the set
point of hypothalamic (preoptic) thermoregulatory
neurons; body temperature
increases (fever).
Vascular smooth muscle. PGE2
and PGI2 produce arteriolar vasodilation;
PGF2!, venoconstriction.
Gastric secretion. PG promote the
production of gastric mucus and reduce
the formation of gastric acid (p. 160).
Menstruation. PGF2! is believed to
be responsible for the ischemic necrosis